Sadhan Das1, Marpadga A Reddy, Rama Natarajan. 1. Department of Diabetes Complications and Metabolism, Beckman Research Institute of City of Hope, Duarte, California, USA.
Abstract
PURPOSE OF REVIEW: Hyperlipidemia, hypertension, diabetes and related metabolic disorders increase the risk for cardiovascular disease (CVD). Despite significant progress in the identification of key mechanisms and genetic polymorphisms linked to various CVDs, the rates of CVDs continue to escalate, underscoring the need to evaluate additional mechanisms for more effective therapies. Environment and lifestyle changes can alter epigenetic mechanisms mediated by histone modifications and long noncoding RNAs (lncRNAs) which play important roles in gene regulation. The review summarizes recent findings on the role of epigenetic mechanisms in CVD. RECENT FINDINGS: Recent studies identified dysregulated histone modifications and chromatin modifying proteins at cis-regulatory elements, including enhancers/super-enhancers, mediating the expression of genes associated with CVD in vascular and immune cells in response to growth factors and inflammatory mediators. Several lncRNAs have also been reported to contribute to pathological gene expression via cis and trans mechanisms involving interactions with nuclear proteins, co-operation with enhancers/super enhancers and acting as microRNA sponges. SUMMARY: Epigenomic approaches in cells affected in CVDs can be exploited to understand the function of genetic polymorphisms at cis-regulatory elements and crosstalk between enhancers and lncRNAs associated with disease susceptibility and progression. The reversible nature of epigenetics provides opportunities for the development of novel therapeutic strategies for CVD.
PURPOSE OF REVIEW: Hyperlipidemia, hypertension, diabetes and related metabolic disorders increase the risk for cardiovascular disease (CVD). Despite significant progress in the identification of key mechanisms and genetic polymorphisms linked to various CVDs, the rates of CVDs continue to escalate, underscoring the need to evaluate additional mechanisms for more effective therapies. Environment and lifestyle changes can alter epigenetic mechanisms mediated by histone modifications and long noncoding RNAs (lncRNAs) which play important roles in gene regulation. The review summarizes recent findings on the role of epigenetic mechanisms in CVD. RECENT FINDINGS: Recent studies identified dysregulated histone modifications and chromatin modifying proteins at cis-regulatory elements, including enhancers/super-enhancers, mediating the expression of genes associated with CVD in vascular and immune cells in response to growth factors and inflammatory mediators. Several lncRNAs have also been reported to contribute to pathological gene expression via cis and trans mechanisms involving interactions with nuclear proteins, co-operation with enhancers/super enhancers and acting as microRNA sponges. SUMMARY: Epigenomic approaches in cells affected in CVDs can be exploited to understand the function of genetic polymorphisms at cis-regulatory elements and crosstalk between enhancers and lncRNAs associated with disease susceptibility and progression. The reversible nature of epigenetics provides opportunities for the development of novel therapeutic strategies for CVD.
Authors: Sebastian Cremer; Katharina M Michalik; Ariane Fischer; Larissa Pfisterer; Nicolas Jaé; Carla Winter; Reinier A Boon; Marion Muhly-Reinholz; David John; Shizuka Uchida; Christian Weber; Wolfgang Poller; Stefan Günther; Thomas Braun; Daniel Y Li; Lars Maegdefessel; Ljubica Perisic Matic; Ulf Hedin; Oliver Soehnlein; Andreas Zeiher; Stefanie Dimmeler Journal: Circulation Date: 2019-03-05 Impact factor: 29.690
Authors: Qiming Duan; Sarah McMahon; Priti Anand; Hirsh Shah; Sean Thomas; Hazel T Salunga; Yu Huang; Rongli Zhang; Aarathi Sahadevan; Madeleine E Lemieux; Jonathan D Brown; Deepak Srivastava; James E Bradner; Timothy A McKinsey; Saptarsi M Haldar Journal: Sci Transl Med Date: 2017-05-17 Impact factor: 17.956
Authors: Lindsey E Montefiori; Debora R Sobreira; Noboru J Sakabe; Ivy Aneas; Amelia C Joslin; Grace T Hansen; Grazyna Bozek; Ivan P Moskowitz; Elizabeth M McNally; Marcelo A Nóbrega Journal: Elife Date: 2018-07-10 Impact factor: 8.140